BOTHELL, Wash., April 22 /PRNewswire-FirstCall/ -- Helix BioMedix (HXBM.OB), a developer of synthetic bioactive peptides, today announced that R. Stephen Beatty, President and Chief Executive Officer, is scheduled to present an overview of the company at Invest Northwest on April 26, 2005, at the Bell Harbor Conference Center, Seattle, Washington. Invest Northwest 2005 is hosted by the Washington Biotechnology and Biomedical Association, in collaboration with BC Biotech, BC MedTech, BioAlberta, Idaho Bioscience Association, Montana Bioscience Alliance and the Oregon Bioscience Association
Helix BioMedix's presentation at Invest Northwest is scheduled for 11:20 am Pacific Time (8:20 am Eastern Time.) Individuals interested in listening to the live presentation can participate via webcast at http://www.helixbiomedix.com/ or at http://www.wsw.com/webcast/in3/hxbm.ob/. A replay of the webcast will also be available for 60 days.
About Helix BioMedix
Helix BioMedix, Inc. is an early-stage biotechnology company that has a portfolio of issued patents that covers six distinct classes of peptides, covering over 100,000 unique peptide sequences. The company's mission is to become the industry leader in developing and commercializing small proteins known as bioactive peptides. The antimicrobial and wound healing properties of these peptides qualify them for inclusion in a wide range of both pharmaceutical and consumer products. The company is currently focused on the development of selected peptides as topical anti-infectives and in wound healing. Non-pharmaceutical applications being pursued by Helix BioMedix include adjuvants for cosmetics/cosmeceuticals, personal care, plant health, animal health and wide-spectrum biocides. More information about the company and its proprietary peptides can be found on the company's website at http://www.helixbiomedix.com/.
Contact: Helix BioMedix, Inc. David Kirske, 425-402-8400 dkirske@helixbiomedix.com or Investor Relations: Cameron Associates Alison Ziegler, 212-554-5469 alison@cameronassoc.com
Helix BioMedix, Inc.CONTACT: David Kirske of Helix BioMedix, Inc., +1-425-402-8400 ordkirske@helixbiomedix.com; or Investor Relations: Alison Ziegler of CameronAssociates, +1-212-554-5469 or alison@cameronassoc.com, for Helix BioMedix,Inc.
Web site: http://www.helixbiomedix.com/
